demonstrated that YY1 was crucial for alterations in lipid metabolism in HCC cells because it suppresses the expression of the PGC-1β, which is a transcriptional activator of MCAD and LCAD that boosts both enzymes’ expression. This evidence concerns the gene YY1 and hepatocellular carcinoma.